The genus Chlamydia (Bedsonia or psittacosislymphogranuloma venereum-trachoma group) includes a large group of obligate intracellular parasites that infect man, birds, and mammals. These agents cause pneumonitis, psittacosis, enteritis, abortion, trachoma, lymphogranuloma venereum, inclusion conjunctivitis, encephalomyelitis, and arthritis. Despite the extensive host range of the chlamydiae and the variety of disease syndromes they produce, there is no convenient method for typing isolates. A recent proposal (13) would divide this large genus into only two species, differentiated by inclusion type and sulfonamide sensitivity, criteria that would place many isolates of diverse origins and different biological properties in the same species. There is a need for a test that can be used to determine the antigenic relationships between the various agents. Conceivably such a test may make possible more precise identification and useful grouping of the chlamydiae.
Subgroups can be separated through the study of pathogenicity patterns in experimental animals (9, 12, 17) , in vivo toxin neutralization or prevention (4, 8, 16) , cross-immunity tests (1, 3, 18) , and infectivity neutralization tests in mice and eggs (6, 11) . The (5, 7) . Fraser and Berman (5) used cell wall antigen in this way and were able to divide 29 different mammalian isolates into 7 serological subgroups. They could not distinguish between the avian isolates. The complexity of these procedures probably accounts for the small number of chlamydial isolates that have been subjected to analysis.
Some workers have used plaque reduction in efforts to demonstrate antigenic specificity. Chapell and Manire (Bacteriol. Proc., p. 118, 1965) showed the specificity of rabbit antiserum prepared against the meningopneumonitis agent. A reduction in plaque count was obtained when this antiserum was mixed with the homologous agent before inoculation onto cells. No reduction was obtained when 6BC (a California parakeet isolate) and a mouse pneumonitis strain were tested with this serum. Piraino obtained effective plaque reduction with pigeon antiserum and found that CF and neutralizing antibodies were distinct (14) . This paper reports the results obtained by using antichlamydial rooster serum in a plaque reduction test. The rooster was the serum source because this and other laboratories had confirmed the early report of Hilleman and Gordon (6) (ip) inoculations of live antigen were given; on day 54 a trial bleeding was performed, and, if serum gave homologous neutralization, the roosters were bled on day 68; if no neutralization occurred, another three ip inoculations were given on days 68, 70, and 72; trial bleedings were made on day 86, and the roosters were either bled out or another series of inoculations was initiated on day 100. Schedule E. Schedule E was used for chlamydial isolates highly virulent for chickens; on day 1, 1 ml of 10-5 live YS suspension was given im; when roosters were clinically ill (usually days 5 to 7), 100 mg of tetracycline was given im followed by tetracyclineimpregnated feed; on day 28, the birds were exsanguinated.
Sera collected from prebleedings were also used as control sera. Because the tests required a large volume of normal serum, additional normal rooster serum was obtained from the Grand Island Biological Co.
(Grand Island, N.Y.). The results of the ICF and CF tests were negative, and this serum did not inhibit plaque formation.
Serum dilutions were made in phosphate-buffered saline (PBS), pH 7.2, enriched with 10% fetal calf serum (enriched PBS) and inactivated at 56 C for 30 min.
Chlamydial isolates. The agents used in this study included strains isolated from turkeys [T-515 (Texas), NJ (New Jersey), and no. 14 (Oregon)], from parrots [AC (Australian), M (Mexico), and B (Brazil)], from parakeets [51C (California)], and from pigeons [SDP (California) and AU46 (California)]. Several chlamydiae of human origin were also used: lymphogranuloma venereum (434-B, 440-LN); fast-growing trachoma-inclusion conjunctivitis (TRIC) strains (T'ang and LB-1).
Plaque assay. The infectivity titrations were performed by plaque assay in mouse fibroblast (L-929) cells (2) . Yolk-sac-grown chlamydial pools were prepared and samples were stored at -70 C until use. All agent dilutions were prepared in enriched PBS. Inocula were standardized to yield from 100 to 250 plaque-forming units (PFU) per petri dish when mixed with an equal amount of normal rooster serum. A 1-ml amount of diluted agent was mixed with an equal amount of diluted antiserum and held overnight at 4 C. A parallel combination was made with normal control serum.
Cell sheets were washed twice with PBS. An inoculum of 0.2 ml of the combined agent and serum was allowed to adsorb at 37 C for 2 hr in a CO2 incubator. Plates were agitated every 30 min to spread the inoculum and keep the cell sheets from drying. Monolayers were then washed twice with PBS, and 5 ml of overlay medium was added. Overlay used in these tests did not contain streptomycin. The plates were incubated at 37 C in a 5 to 10% concentration of CO2 in air at 70 to 85% relative humidity.
LGV and TRIC agents were also incubated at 37 C. On day 7, the plates were fed another 5 ml of overlay medium; on day 13, a third overlay containing 1:10,000 neutral red was added. Plaques were counted on day 14. Serum titers are expressed as that dilution reducing the plaque count to 50% of the control counts. The Reed and Muench formula was used to calculate the 50% end-point titers (15) .
Factors affecting the antigen-antibody combination. The optimal time and temperature for the antigenantibody interaction were determined. A 6-ml amount of a 104 dilution of a chlamydial isolate from an Australian Eclectus parrot was prepared in PBS, mixed, and divided between two tubes. To one tube we added 3 ml of a 1: 5 dilution of inactivated control rooster serum in enriched PBS, and to the other we added 3 most experiments, only one of the three or four immunized roosters produced measurable neutralizing antibody. For some isolates, high-titered neutralizing antibody titers were not achieved. None of the immunization schedules was consistently superior to the others. Schedule A produced some high-titered sera, but many roosters died after the iv inoculation. Schedule E gave poor yields in terms of volumes of sera, as surviving birds were often debilitated.
In preliminary experiments, the nine antisera prepared against avian chlamydiae were also tested for ability to reduce plaque counts of chlamydial isolates other than homologous strains by either screening or end-point titration against some representative chlamydiae within the Hooper Foundation collection. The isolates included 26 from turkeys, 10 from parrots, 6 from parakeets, and 10 from pigeons. The antisera often did not reduce the plaque counts of various heterologous isolates. The results indicate that chlamydiae from one avian genus may have a closer antigenic relationship to one another than to chlamydiae from other avian hosts (Table  3) . Although some differences emerged, the turkey isolates all appeared to be antigenically related, even though the antisera were prepared against VOL. 2, 1970 445 With some sera, an occasional heterologous titer was higher than the homologous titers. Some highly potent antisera appeared to have a very broad spectrum. For example, antiserum 59, against an Oregon turkey isolate, reduced the plaque counts of isolates from 24 turkeys, 1 parrot, 3 parakeets, and 2 pigeons (Table 3 ). The only negative result with this serum was against a parrot strain. Interestingly, serum against the other two turkey strains did not reduce the plaque count of the Oregon turkey isolate. The evidence for host specificity in Table 3 would be more impressive but for the results with this serum.
DISCUSSION
The plaque neutralization test is not generally used for routine survey or identification because it is time-consuming and exacting. It is widely used, however, in the study of basic properties of viruses and bacteria when accuracy and sensitivity are essential. This is particularly true when one is trying to determine antigenic relationships of agents, to detect antigenic variants, and to analyze agent populations. Since the dose of agent employed is small, 100 to 250 PFU, the method is sensitive for detecting neutralizing antibodies.
When strict attention was paid to certain technical details, the plaque reduction technique proved suitable for assay of neutralizing antibody against chlamydiae. The antigen-antibody mixtures should react at 4 C and not be incubated for 1 or 2 hr at 37 C because thermal inactivation of the agents complicates the interpretation of results. When PBS without serum was used as the diluent for agent and serum, we observed greater plaque count in the antiserum-agent sample with some heterologous isolates than in the control serum-agent sample. This did not happen con- 
